Dry skin
Conditions
Interventions
Piceatannol group: Duration: 8 weeks Test material:supplement containing piceatannol (capsules) 2 capsules per day
Placebo group: Duration: 8 weeks Test material: placebo(capsules) 2 capsules pe
Sponsors
MORINAGA & CO., LTD.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Healthy female from 35 to 55 years old who is troubled by dry skin
Exclusion criteria
Exclusion criteria: 1. Subjects who take medicine with chronic diseases. 2. Subjects with atopic dermatitis or chronic dermatitis. 3. Subjects who have possibilities for excessive sunburn. 4. Subjects who have severe allergy to foods and medicine. 5. Subjects who are pregnant or lactating, or planned to become pregnant in the near future. 6. Subjects who have a history of serious disorder. 7. Subjects who are under treatment by physician. 8. Subjects with severe anemia. 9. Subjects who have possibilities for lifestyle change during this study. 10. Subjects who have allergy to cosmetics and ingredients. 11. Subjects who are participating in other clinical studies. 12. Subjects who are judged as unsuitable for this study by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measurement of skin condition (measurement time: 0,4,8 weeks after ingestion of supplement) | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog scale (measurement time: 0,4,8 weeks after ingestion of supplement) SF-36v2 score (measurement time: 0,4,8 weeks after ingestion of supplement) Measurement of microflora (measurement time: 0,4 weeks after ingestion of supplement) | — |
Countries
Japan
Contacts
Public ContactHiroko Uchida
MORINAGA & CO., LTD. Health and Wellness Headquarters
Outcome results
None listed